Cancer Incidence Among Users of Glucagon-Like Peptide-1 Receptor Agonists
GLP-1RA use was associated with a lower incidence of liver and pancreatic cancer, with no increased risk observed for other major cancers. As these medications become more widely used, further research is warranted to better define their long-term cancer-related safety profile.
Authors
- Selamawit Woldesenbet
- Khalid Mumtaz
- Mujtaba Khalil
- Timothy M. Pawlik
- Areesh Mevawalla
- Zayed Rashid
- Shahzaib Zindani
- Azza Sarfraz
- Abdullah Altaf
Institutions
- Conemaugh Health System (US)
- The Ohio State University Wexner Medical Center (US)
- Conemaugh Memorial Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Journal of General Internal Medicine
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1007/s11606-026-10300-1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ohio State University